“…These venom components are commonly named conotoxins, a unique and remarkably diverse group of bioactive peptides with various pharmacological functions [6,14,15,16,17], which target a wide variety of ion channels, receptors, and even their subtypes in preys, predators, and humans with high affinity and specificity [6,18,19,20]. Consequently, conotoxins have become a research hotspot for the treatment of various neuropathic diseases, such as neuralgia, epilepsy, addiction, and Parkinson’s disease [6,21,22,23,24,25,26,27,28,29,30,31].…”